2010
DOI: 10.1542/peds.2010-0433
|View full text |Cite
|
Sign up to set email alerts
|

Lactobacillus reuteriDSM 17938 in Infantile Colic: A Randomized, Double-Blind, Placebo-Controlled Trial

Abstract: L. reuteri DSM 17 938 at a dose of 10(8) colony-forming units per day in early breastfed infants improved symptoms of infantile colic and was well tolerated and safe. Gut microbiota changes induced by the probiotic could be involved in the observed clinical improvement.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

15
288
2
31

Year Published

2013
2013
2016
2016

Publication Types

Select...
8
1

Relationship

3
6

Authors

Journals

citations
Cited by 305 publications
(336 citation statements)
references
References 27 publications
15
288
2
31
Order By: Relevance
“…To fill this gap, this study investigated the composition of microbiota, with respect to specific groups of colonic bacteria claimed to exert an influence on infantile colic of breastfed infants (16), in formula-fed infants with and without colic. For this reason, we chose to use fluorescent in situ hybridisation (FISH) to enumerate coliforms (Enterobacteriaceae), lactic acid bacteria (LAB) and bifidobacteria, in order to establish whether the extent of colonisation differed between the two groups.…”
Section: Key Notesmentioning
confidence: 99%
“…To fill this gap, this study investigated the composition of microbiota, with respect to specific groups of colonic bacteria claimed to exert an influence on infantile colic of breastfed infants (16), in formula-fed infants with and without colic. For this reason, we chose to use fluorescent in situ hybridisation (FISH) to enumerate coliforms (Enterobacteriaceae), lactic acid bacteria (LAB) and bifidobacteria, in order to establish whether the extent of colonisation differed between the two groups.…”
Section: Key Notesmentioning
confidence: 99%
“…Although data on gut health in infants are scanty [12,13,15,16], many recent clinical trials suggest that probiotic administration in early infancy could be useful for the prevention and treatment of many disorders: modulation of the intestinal microbiota through use of probiotics has been suggested as strategy for preventing NEC, atopic eczema and managing infantile colic symptoms.…”
Section: Discussionmentioning
confidence: 99%
“…• Third, there is growing evidence that the intestinal microbiota in colicky infants differ from those in healthy controls, since higher levels of anaerobic bacteria, such as coliform and Escherichia coli, and a lower concentration of Lactobacilli have been reported in infants with colic (Savino 2010a;Savino 2013b).…”
Section: Description Of the Conditionmentioning
confidence: 99%
“…Given the growing evidence that the intestinal microbiota in colicky infants differ from those in healthy controls, it is proposed that supplying probiotic bacteria can redress this balance and provide a healthier intestinal microbiota landscape (Savino 2010a;Savino 2013a, Savino 2013b. As the evidence base suggests, common factors impact this colonisation process, such as birth by caesarean section (Grönlund 1999), and it is proposed that offering probiotics prophylactically to all as a form of primary prevention could offer significant benefit to the population with minimal risk.…”
Section: How the Intervention Might Workmentioning
confidence: 99%